Form 8-K - Current report:
SEC Accession No. 0000950123-11-061823
Filing Date
2011-06-27
Accepted
2011-06-27 11:10:18
Documents
2
Period of Report
2011-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c19281e8vk.htm 8-K 18095
2 EXHIBIT 2.1 c19281exv2w1.htm EX-2.1 157036
  Complete submission text file 0000950123-11-061823.txt   176569
Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52998 | Film No.: 11932156
SIC: 2834 Pharmaceutical Preparations